ANAPHYLAXIS - Nursing Case Study
Pathophysiology
• Primary mechanism: Anaphylaxis is primarily triggered by the rapid release of immunoglobulin E (IgE) antibodies in response to an allergen, leading to widespread mast cell and basophil activation. These cells release histamines and other mediators, causing vasodilation and increased vascular permeability, which result in hypotension and edema.
• Secondary mechanism: The release of leukotrienes and prostaglandins further exacerbates the inflammatory response, contributing to bronchoconstriction and respiratory distress, which are critical in acute anaphylactic episodes.
• Key complication: The rapid onset of systemic vasodilation and fluid shift into tissues can lead to circulatory collapse and shock, requiring immediate intervention to prevent severe outcomes.
Patient Profile
Demographics:
28-year-old female, nurse
History:
• Key past medical history: Mild asthma, seasonal allergies
• Current medications: Albuterol inhaler as needed, loratadine daily
• Allergies: Peanuts, penicillin
Current Presentation:
• Chief complaint: Difficulty breathing after exposure to peanuts
• Key symptoms: Swelling of the lips and face, hives on the chest, wheezing, dizziness
• Vital signs: Blood pressure 90/60 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, temperature 98.6°F, oxygen saturation 91% on room air
Section 1
As the medical team responds to the anaphylactic emergency, the initial assessment reveals worsening respiratory distress and cardiovascular instability. Despite prompt administration of intramuscular epinephrine, the patient's oxygen saturation remains critically low at 88% on room air, and her wheezing has intensified. The nurse notes that the patient's skin is cool and clammy, and her level of consciousness is decreasing, indicated by her delayed responses to verbal stimuli. As the team continues to monitor vital signs, her blood pressure drops further to 85/55 mmHg, and her heart rate remains elevated at 130 bpm, suggesting ongoing compensatory tachycardia due to hypotensive shock.
The team quickly administers supplemental oxygen via a non-rebreather mask, increasing her oxygen saturation to 93%. However, her respiratory rate remains high at 32 breaths per minute. Simultaneously, intravenous access is established, and a bolus of normal saline is initiated to counteract the hypotensive effects of vasodilation and fluid shifts. The attending physician orders a stat serum tryptase level to confirm the anaphylactic reaction and assesses for potential biphasic anaphylaxis, as the patient continues to exhibit severe symptoms despite initial treatment.
As the patient's condition is closely monitored, a new complication arises: audible stridor suggests the development of laryngeal edema, posing a significant risk for airway obstruction. This development necessitates immediate intervention. The team prepares for advanced airway management, considering intubation if her airway becomes compromised. The rapid progression of symptoms underscores the severity of her anaphylactic reaction, prompting the clinical team to reassess and adjust the treatment plan dynamically to stabilize her condition and prevent further deterioration.
Section 2
As the clinical team continues to intervene, they note a change in the patient's status indicating further deterioration. Despite supplemental oxygen and fluid resuscitation, her oxygen saturation begins to fluctuate, dipping back to 90%, and her respiratory rate remains elevated, now reaching 34 breaths per minute. The previously noted stridor becomes more pronounced, and her voice is barely audible, suggesting further progression of laryngeal edema. Conscious of the critical need to secure the airway, the team prepares for rapid sequence intubation. The anesthesiologist evaluates the patient's airway and decides that intubation is immediately necessary to prevent complete airway obstruction.
Meanwhile, the lab results for the stat serum tryptase level return, confirming elevated levels consistent with an anaphylactic reaction. This finding corroborates the diagnosis, and the physician orders an additional dose of intramuscular epinephrine, alongside intravenous corticosteroids and antihistamines, to further mitigate the allergic response. Despite these efforts, the patient develops a new complication: her blood pressure continues to drop to a precarious 78/50 mmHg, highlighting the severity of distributive shock. The medical team increases the rate of the normal saline infusion and considers vasopressor support to stabilize her hemodynamics.
In response to these interventions, the patient's condition shows partial stabilization. After successful intubation, her oxygen saturation improves to 95%, and her respiratory rate decreases to 24 breaths per minute. However, her blood pressure remains borderline, necessitating ongoing vigilance and titration of supportive measures. The team recognizes the potential for biphasic anaphylaxis and prepares to monitor her closely for any delayed resurgence of symptoms. This critical juncture emphasizes the importance of dynamic clinical reasoning in managing complex and rapidly evolving emergencies, ensuring that every decision is informed by the latest assessment and diagnostic data.
Section 3
As the team continues to monitor the patient closely, they observe a further change in her status. Approximately two hours after the initial interventions, the patient begins to exhibit signs of gastrointestinal distress, including increased abdominal pain and diarrhea. These symptoms suggest a possible secondary inflammatory response, a known but less common complication of anaphylaxis. Conscious of the potential for intestinal hypoperfusion due to ongoing hypotension, the team decides to conduct an abdominal ultrasound to rule out any significant ischemic changes.
Concurrent with these developments, the patient’s laboratory results from the earlier arterial blood gas (ABG) analysis are received, revealing a mixed respiratory and metabolic acidosis. The pH stands at 7.28, pCO2 at 50 mmHg, and HCO3- at 18 mEq/L. These findings indicate inadequate respiratory compensation and metabolic derangement, possibly exacerbated by the persistent hypotension and ensuing hypoperfusion of vital organs. This necessitates a reassessment of the current management strategy to address both respiratory insufficiency and metabolic imbalance.
In response to these new diagnostic insights, the clinical team adjusts the ventilator settings to improve ventilation and oxygenation, while also modifying the fluid resuscitation plan to include balanced electrolyte solutions to correct the metabolic acidosis. Vasopressor support is initiated with a low-dose norepinephrine infusion, aiming to restore adequate perfusion pressure and prevent further organ dysfunction. The team remains vigilant for signs of biphasic anaphylaxis, understanding that the resolution of the acute phase does not preclude a secondary wave of symptoms. This situation underscores the necessity for ongoing, dynamic clinical reasoning to adapt to the evolving clinical picture, ensuring all therapeutic interventions are responsive to the patient's immediate and potential needs.
Section 4
As the clinical team continues to manage the patient's condition, a new complication arises approximately four hours after the initial intervention. Despite the adjustments in ventilator settings and fluid resuscitation, the patient’s oxygen saturation begins to decline, dropping to 88% on a fraction of inspired oxygen (FiO2) of 60%. Additionally, her heart rate increases to 115 beats per minute, and blood pressure remains labile with readings fluctuating between 85/50 mmHg and 95/60 mmHg. These changes prompt the team to perform a repeat arterial blood gas (ABG) analysis, which reveals a persistent acidosis with a pH of 7.30, a pCO2 of 52 mmHg, and a HCO3- of 19 mEq/L. The rising pCO2 suggests worsening respiratory acidosis, indicating inadequate ventilation despite previous adjustments.
In light of the declining oxygen saturation and potential respiratory fatigue, the clinical team deliberates the possibility of escalating respiratory support. They consider the need for non-invasive ventilation or intubation to ensure adequate gas exchange and prevent further hypoxemic injury. Concurrently, they reassess the ongoing use of vasopressors, debating whether an increase in norepinephrine dosing is warranted to better stabilize hemodynamics and enhance tissue perfusion.
Recognizing the need for a multifaceted approach, the team also reviews the latest echocardiogram results, which show a decreased ejection fraction suggestive of stress-induced cardiomyopathy, likely secondary to anaphylactic shock. This finding complicates the management of fluid resuscitation, as excessive fluid could exacerbate cardiac dysfunction. Therefore, they decide to carefully titrate fluids while optimizing vasopressor support, closely monitoring for any signs of fluid overload or cardiac compromise. These developments highlight the intricate balance required in managing the patient’s evolving clinical status, necessitating continuous evaluation and adjustment of therapeutic strategies to mitigate further complications and promote recovery.
Section 5
As the clinical team continues to monitor the patient closely, they observe a new complication arising approximately six hours after the initial intervention. The patient begins to exhibit signs of acute renal dysfunction, with a marked decrease in urine output to less than 20 mL/hour. Laboratory results confirm a significant rise in serum creatinine from 1.0 mg/dL at admission to 2.8 mg/dL, alongside an elevated blood urea nitrogen (BUN) level of 42 mg/dL. These findings suggest the onset of acute kidney injury (AKI), likely secondary to hypoperfusion from the ongoing hemodynamic instability and potential nephrotoxic effects from medications administered during the anaphylactic event.
In response to the development of AKI, the team decides to initiate renal protective strategies. They adjust the dosing of nephrotoxic medications and focus on maintaining adequate perfusion pressure without exacerbating fluid overload. Continuous renal replacement therapy (CRRT) is considered if urine output does not improve and metabolic acidosis worsens. Meanwhile, the patient’s blood pressure continues to fluctuate, necessitating further titration of vasopressor support. The norepinephrine infusion is increased incrementally, with close monitoring of the patient's hemodynamic response.
The emergence of renal complications adds another layer of complexity to the patient's care, prompting a reevaluation of the overall management plan. The team is challenged to balance the need for aggressive support of vital functions with the risk of further organ dysfunction. This situation underscores the importance of a dynamic and integrated approach, where clinical reasoning is continuously applied to adjust interventions based on the patient’s evolving condition. The next steps will focus on stabilizing renal function, optimizing cardiac output, and ensuring adequate oxygenation to facilitate recovery from the anaphylactic shock.